Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.

Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. Lancet Gastroenterol Hepatol. 2016 10; 1(2):122-132.

View in: PubMed

subject areas

Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Antiviral Agents
Carbamates
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Hepatitis C, Chronic
Heterocyclic Compounds, 4 or More Rings
Humans
Intention to Treat Analysis
Liver Cirrhosis
Male
Middle Aged
Patient Reported Outcome Measures
Prospective Studies
Ribavirin
Sofosbuvir
Treatment Outcome
Young Adult

authors with profiles

Michael Charlton